HCM
EVH icon

Hodges Capital Management’s Evolent Health EVH Stock Holding History

Hodges Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-218,240
Closed -$6.17M – 207
2024
Q3 		$6.17M Sell
218,240
-287,395
-57% -$7.41M 0.4% 75
2024
Q2 		$9.67M Buy
505,635
+30,889
+7% +$789K 0.65% 46
2024
Q1 		$15.6M Buy
474,746
+208,534
+78% +$6.65M 0.99% 29
2023
Q4 		$8.79M Buy
+266,212
New +$7.53M 0.47% 59

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Hodges Capital Management's EVH Position: Q4 2024 in Review

Hodges Capital Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 218,240 shares — an estimated $6.17M sold.

Hodges Capital Management first reported a position in EVH in Q4 2023 and held it in 4 quarters. The position peaked at $15.6M in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Hodges Capital Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Hodges Capital Management sold 218,240 Evolent Health shares in Q4 2024, an estimated $6.17M.
  • Hodges Capital Management first reported a position in Evolent Health in Q4 2023 and held it in 4 quarters.
  • Hodges Capital Management's Evolent Health position peaked at $15.6M in Q1 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Hodges Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.